CN EN

news

BioDuro-Sundia Wins Premium Global Partner at CPHI China Pharma Awards 2024

BioDuro-Sundia, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO) and an Advent International portfolio company, announced that it has been named "Premium Global Partner" at CPHI China Pharma Awards 2024.
June 20, 2024

BioDuro-Sundia’s Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167

BioDuro-Sundia’s Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167 | BioDuro-Sundia | Moving You Forward
March 26, 2024

StoneWise Awards BioDuro-Sundia FTE team in Chemistry Department for Best Contributing Team of 2023

The technical services of BioDuro-Sundia FTE team of Chemistry Department were once again recognized by its partners | StoneWise Awards BioDuro-Sundia
February 06, 2024

Inna Pharma Presents "2023 Outstanding Partner Award" to BioDuro-Sundia CMC Team

Inna Pharma presented the "2023 Outstanding Partner Award" to BioDuro-Sundia's CMC team in Shanghai on December 26, recognizing their exceptional ...
December 26, 2023

Asieris Pharmaceuticals Presents "2023 Outstanding Contribution Award" to BioDuro-Sundia Formulation Team

The pre-formulation team of BioDuro-Sundia Formulation Department has been awarded the "2023 Outstanding Contribution Award" for its outstanding performance ...
December 15, 2023
Total 85 12345678...1617
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all